Regulatory Applications

Richmond Pharmacology will undertake all regulatory matters on behalf of our clients, depending on their requirements. Our experienced project management team will compile all necessary documentation, including writing the information for volunteers, informed consent form and completing the on-line IRAS application form.

Richmond Pharmacology can obtain necessary documentation and specialist opinions for ethics submissions, in order to obtain approvals in a timely manner. We work closely with many ethics committees, local and nationwide, and will select an ethics committee based on study needs.

If required, the Principal Investigator will attend the ethics committee meeting to participate in discussions and ensure a smooth approval process.

As well as working with many Phase I ethics committees, we also work closely with our local ethics committee which approves Phase II studies. If required, we will obtain R&D approval for a specific site, a process of which Richmond Pharmacology has extensive experience.

Richmond Pharmacology will also organise and oversee the CTA application to the MHRA if required. We have submitted numerous CTAs to the MHRA on behalf of our clients, typically gaining approval after the first review of the study documentation.

Latest news

Dr Arezina article published in GMP review

16th Aug 2018

Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review

Read more ›

Richmond Pharmacology Confirm event with the Department of International Trade

08th Aug 2018

Richmond Pharmacology is delighted to confirm an upcoming event alongside the Department of International Trade in

Read more ›

Officially an ILS Resuscitation Council Course Centre

07th Mar 2018

Richmond Pharmacology’s London Bridge Unit is now officially an ILS Resuscitation Council Course Centre. The

Read more ›

Early Phase Drug Development in the UK

25th Jan 2019

Richmond Pharmacology with support from the Department of International trade will be participating in an event to

View event ›